Sign in
4

Changes in Ownership

Spero Therapeutics, Inc. Filed Acc 0000950170-25-112659

Chief Operating Officer sold 1,695 shares at $1.97 ($3,339)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Keutzer Timothy Chief Operating Officer 2025-08-28 Sale −1,695 $1.97 $3,339 739,744 D
Open-market sales · 1,695 sh · avg $1.97 · $3,339
Loading xslF345X05/ownership.xml…